RichardVoitMD

Dana Farber Cancer Institute

Dr. Voit is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
5323 Harry Hines Boulevard
Dallas, TX 75390
Phone+1 214-456-2382

Fax+1 214-456-6133

Richard Voit, MD, is a pediatric hematology and oncology specialist based in Dallas, TX. He completed his medical education at the University of Texas Southwestern Medical School and his pediatrics residency at Boston Children's Hospital/Boston Medical Center. His research focuses on gene therapy and hematopoietic cell regulation, with several publications in prominent journals such as Cell Stem Cell, Journal of Clinical Immunology, Haematologica, Blood Advances, and Nature Immunology. His work has been cited by other researchers, indicating engagement with the scientific community.

Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 2014 - 2017
University of Texas Southwestern Medical SchoolClass of 2014

PubMed

2 citations
Regulated GATA1 expression as a universal gene therapy for Diamond-Blackfan anemia.
Richard A Voit, Xiaotian Liao, Alexis Caulier, Mateusz Antoszewski, Blake Cohen
Cell Stem Cell. 2025-01-02
CEBPA repression by MECOM blocks differentiation to drive aggressive leukemias.
Travis J Fleming, Mateusz Antoszewski, Sander Lambo, Michael C Gundry, Riccardo Piussi
Biorxiv. 2024-12-30
2 citations
Gene therapy for congenital marrow failure syndromes - no longer grasping at straws?
Richard A Voit, Seth J Corey
Haematologica. 2023-11-01

A Universal Gene Therapy for Diamond-Blackfan Anemia Is Poised for Clinical TestingNovember 21st, 2024
Universal Gene Therapy for Blood Disorders Targets Downstream PathwaysNovember 14th, 2024